{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:45:20Z","timestamp":1790163920296,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bpobgyn.2025.102683","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:35:23Z","timestamp":1761550523000},"page":"102683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT)"],"prefix":"10.1016","volume":"103","author":[{"given":"R.","family":"Pothof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.W.","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lopriore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Winkelhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.T.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102683_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1471-0528.2010.02657.x","article-title":"Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review","volume":"117","author":"Kamphuis","year":"2010","journal-title":"Bjog"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102683_bib2","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/S2352-3026(23)00271-5","article-title":"Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study","volume":"10","author":"de Vos","year":"2023","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102683_bib3","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102683_bib4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.5114\/aoms.2016.63600","article-title":"Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a","volume":"14","author":"D\u0119bska","year":"2018","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102704","article-title":"Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia","volume":"59","author":"de Vos","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/IJWH.S90753","article-title":"Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities","volume":"9","author":"Tiller","year":"2017","journal-title":"Int J Womens Health"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjh.17731","article-title":"Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia","volume":"195","author":"de Vos","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/trf.15152","article-title":"Risk of HPA-1a-immunization in HPA-1a-negative women after giving birth to an HPA-1a-positive child","volume":"59","author":"Kjeldsen-Kragh","year":"2019","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bjh.17763","article-title":"Are HPA-5b antibodies a significant cause of FNAIT and associated bleeding or merely an incidental finding?","volume":"195","author":"Curtis","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjh.18173","article-title":"Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?","volume":"198","author":"Alm","year":"2022","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102683_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25503","article-title":"Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia","volume":"94","author":"Jin","year":"2019","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102683_bib13","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bpobgyn.2025.102683_bib14","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bpobgyn.2019.01.017","article-title":"Foetal and neonatal alloimmune thrombocytopenia","volume":"58","author":"Winkelhorst","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1471-0528.2008.02068.x","article-title":"Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme","volume":"116","author":"Tiller","year":"2009","journal-title":"Bjog"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib18","series-title":"Fetal and neonatal alloimmune thrombocytopenia: the proof of the pudding is in the eating [Doctoral Thesis]","author":"de Vos","year":"2023"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102683_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2007-994382","article-title":"Screening primiparous women and newborns for fetal\/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group","volume":"13","author":"Durand-Zaleski","year":"1996","journal-title":"Am J Perinatol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102683_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102683_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-3083.2009.02339.x","article-title":"Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program","volume":"70","author":"Skogen","year":"2009","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102683_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.12515","article-title":"A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn","volume":"93","author":"Killie","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102683_bib23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1537-2995.2007.01273.x","article-title":"HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102683_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.21307\/immunohematology-2019-401","article-title":"Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia?","volume":"21","author":"Bessos","year":"2005","journal-title":"Immunohematol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102683_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/aogs.13320","article-title":"Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program","volume":"97","author":"Kjaer","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102683_bib26","first-page":"492","article-title":"Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland","volume":"110","author":"Davoren","year":"2003","journal-title":"Bjog"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102683_bib27","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102683_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-0528.2007.01289.x","article-title":"Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia","volume":"114","author":"Killie","year":"2007","journal-title":"Bjog"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib29","article-title":"Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: a cost-utility analysis","author":"de Vos","year":"2024","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102683_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000488280","article-title":"Perinatal outcome and long-term neurodevelopment after intracranial haemorrhage due to fetal and neonatal alloimmune thrombocytopenia","volume":"45","author":"Winkelhorst","year":"2019","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102683_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102683_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102683_bib35","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1016\/S2352-3026(22)00243-5","article-title":"Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study","volume":"9","author":"de Vos","year":"2022","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102683_bib36","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1471-0528.2011.03039.x","article-title":"Noninvasive fetal genotyping of human platelet antigen-1a","volume":"118","author":"Scheffer","year":"2011","journal-title":"Bjog"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102707","article-title":"Foetal and neonatal alloimmune thrombocytopenia - the role of the HLA-DRB3\u221701:01 allele for HPA-1a-immunisation and foetal\/neonatal outcome","volume":"59","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"14","key":"10.1016\/j.bpobgyn.2025.102683_bib38","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1182\/bloodadvances.2020002137","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3\u221701:01 on fetal\/neonatal outcome","volume":"4","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102683_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102708","article-title":"Recent advances in non-invasive fetal HPA-1a typing","volume":"59","author":"Nogu\u00e9s","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102683_bib43","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1111\/1471-0528.15642","article-title":"Prenatal management of pregnancies at risk of fetal neonatal alloimmune Thrombocytopenia (FNAIT): scientific impact paper no. 61","volume":"126","author":"Regan","year":"2019","journal-title":"Bjog"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102705","article-title":"Progress and development of platelet antibody detection","volume":"59","author":"Porcelijn","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102683_bib45","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bpobgyn.2025.102683_bib46","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1111\/trf.15454","article-title":"Fast and low-cost direct ELISA for high-throughput serological HPA-1a typing","volume":"59","author":"Winkelhorst","year":"2019","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102683_bib47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/aogs.13150","article-title":"Women's attitude towards routine human platelet antigen-screening in pregnancy","volume":"96","author":"Winkelhorst","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102683_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102683_bib49","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/1471-0528.13343","article-title":"True risk of fetal\/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study","volume":"123","author":"Tiller","year":"2016","journal-title":"Bjog"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib50","unstructured":"Vos TWd. Fetal and neonatal alloimmune thrombocytopenia: the proof of the pudding is in the eating 2023, April 13.."},{"key":"10.1016\/j.bpobgyn.2025.102683_bib51","author":"Corporation"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102711","article-title":"Fetal and neonatal alloimmune thrombocytopenia - the Norwegian management model","volume":"59","author":"Tiller","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib53","article-title":"Foetale en Neonatale Allo-Immuun Trombocytopenie (FNAIT): een nieuw voorgesteld beleid","author":"Pothof","year":"2024","journal-title":"Ned Tijdschr Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102683_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of Fetal\/Neonatal Alloimmune Thrombocytopenia: a systematic review","volume":"114","author":"Kjaer","year":"2019","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102683_bib55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/tme.12018","article-title":"Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia","volume":"23","author":"Sainio","year":"2013","journal-title":"Transfus Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102683_bib56","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00431-006-0389-4","article-title":"Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG","volume":"166","author":"te Pas","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102683_bib57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib59","author":"Johnson"},{"key":"10.1016\/j.bpobgyn.2025.102683_bib60","article-title":"Design of a phase 3, global, multicenter, randomized, Placebo-Controlled, double-blind Study of nipocalimab in pregnancies at risk for severe hemolytic disease of the fetus and newborn","author":"Komatsu","year":"2024","journal-title":"Am J Perinatol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:41:10Z","timestamp":1764780070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S1521693425001075"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102683","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102683"}}